Adenovirus vectors for gene therapy

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4353201, 435455, 435456, 435 914, 536 2372, 536 241, C12N 1563, C12N 1564, C12N 15861, C07H 2104

Patent

active

061400874

ABSTRACT:
The invention comprises a series of adenovirus-based vectors having deletions in the E1 and/or E3 regions, and also insertions of pBR322 sequences, which can be used to deliver nucleic acid inserts into host cells, tissues or organisms that then can express the insert. The invention includes the use of the vectors in introducing genes into cells, in making vaccines and in gene therapy.

REFERENCES:
patent: 4510245 (1985-04-01), Cousens et al.
patent: 4797368 (1989-01-01), Carter et al.
patent: 4920209 (1990-04-01), Davis et al.
patent: 4920211 (1990-04-01), Tibbetts et al.
patent: 5882877 (1999-03-01), Gregory et al.
Graham et al, Methods in Molecular Biology, 7:109-128 (1991).
Quantin et al., PNAS, vol. 89, pp. 2581-2584, Apr. 1992.
Yang et al., Proc. Natl. Acad. Sci. USA, 91:4407-4411 (1994).
Wolff, JA, Current Opinion in Neurobiology, 3:743-748 (1993).
Neuwalt et al., Behaviorial and Brain Sciences, 18:1-9 (1995).
B. Quantin, et al., "Adenovirus as an Expression Vector in Muscle Cells In Vivo", Proc. Natl. Acad. Sci. USA, vol. 89, 1992, pp. 2581-2584.
M. Rosenfeld, et al., "In Vivo Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator Gene to the Airway Epitehlium", Cell, vol. 68, 1992, pp. 143-155.
W.J. McGrory et al., "A Simple Technique for the Rescue of Early Region I Mutations into Infectious Human Adenovirus Type", Virology 163, 1988, pp. 614-617.
G. Ghoush-Choudhury et al., "Human Adenovirus Cloning Vectors Based on Infectious Bacterial Plasmids", Gene 50, 1966, pp. 161-171.
Tomas Hanke et al., "Identification of an Immunodominant Cytooxic T-Lymphocyte Recognition Site in Glycoprotein B of Herpes Simplex Virus by Using Recombinant Adenovirus Vectors and Synthetic Peptides", Journal of Virology, 65 (3), 1991, pp. 1177-1186.
S.K. Mittal et al. (1993) Virus Res. 28, 67-90.
K.L. Berkner et al., "Generation of Adenovirus by Transfection of Plasmids", Nucleic Acids Research, 11(17), 1983, pp. 6003-6020.
Y. Haj-Ahmad et al., "Development of a Helper-Independent Human Adenovirus Vector and its Use in the Transfer of the Herpes Simplex Virus Thymidine Kinase Gene", Journal of Virology, 57(1), 1986, pp. 267-274.
N. Jones and T. Shenk, "Isolation of Adenovirus Type 5 Host Range Deletion Mutants Defective for Transformation of Rat Embryo Cells", Cell, 17, 1979, pp. 683-689.
D.S. Bautista et al., "Isolation and Characterization of Insertion Mutants in E1A of Adenovirus Type 5", Virology, 182, 1991, pp. 578-596.
F.L. Graham, "Covalently Closed Circules of Human Adenovirus DNA are Infectious", The EMBO Journal, 3(12), 1984, pp. 2917-2922.
M. Ruben et al. "Covaltently Closed Circules of Adenovirus 5 DNA" (1983) Nature 301: 172-174.
P. Hearing et al., "Identification of a Repeated Sequence Element Required to Efficient Encapsidation of the Adenovirus Type 5 Chromosome", Journal of Virology, 61(8), 1987, pp. 2555-2558.
N.D. Stow, "The Infectivity of Adenovirus Genomes Lacking DNA Sequences from their Left-hand Termini", Nucleic Acids Research, 10(17), 1982, pp. 5105-5119.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Adenovirus vectors for gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adenovirus vectors for gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenovirus vectors for gene therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2050047

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.